Heterozygous and Inherited Mutations in the Smooth Muscle Actin () Gene Underlie Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome

English version České info

In 1976, a radiologist, Walter Berdon described a group of patients with a rare intestinal and bladder disorder in which the smooth muscle of those organs failed to contract. These patients are unable to digest food, require multiple abdominal surgeries and are diagnosed with megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS). Since the description of MMIHS, the genes that cause it have remained a mystery. We followed and obtained DNA from patients with this disorder over a period of over 14 years and assembled a large group of cases. We used whole-exome sequencing, a powerful tool used to identify disease genes, and found mutations in ACTG2, a visceral actin gene. Actins are components of muscle contractile units, and one Finnish family has been previously found with less severe gastrointestinal problems due to mutations in this gene. In our patients, we find de novo mutations in the majority of cases of MMIHS. However, we also find families with the disease over several generations due to these same mutations. This work provides the first disease gene for MMIHS, and suggests new treatment options.

Vyšlo v časopise: Heterozygous and Inherited Mutations in the Smooth Muscle Actin () Gene Underlie Megacystis-Microcolon-Intestinal Hypoperistalsis Syndrome. PLoS Genet 10(3): e32767. doi:10.1371/journal.pgen.1004258
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004258

Souhrn

Zdroje

1. BerdonWE, BakerDH, BlancWA, GayB, SantulliTV, et al. (1976) Megacystis-microcolon-intestinal hypoperistalsis syndrome: a new cause of intestinal obstruction in the newborn. Report of radiologic findings in five newborn girls. AJR Am J Roentgenol 126: 957–964.

2. GosemannJH, PuriP (2011) Megacystis microcolon intestinal hypoperistalsis syndrome: systematic review of outcome. Pediatr Surg Int 27: 1041–1046.

3. KohlerM, PeasePW, UpadhyayV (2004) Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) in siblings: case report and review of the literature. Eur J Pediatr Surg 14: 362–367.

4. PuriP, ShinkaiM (2005) Megacystis microcolon intestinal hypoperistalsis syndrome. Semin Pediatr Surg 14: 58–63.

5. SchulerH, NyakernM, SchuttCE, LindbergU, KarlssonR (2000) Mutational analysis of arginine 177 in the nucleotide binding site of beta-actin. Eur J Biochem 267: 4054–4062.

6. ArslanM, BayraktarY, OksuzogluG, OzdemirA, SokmensuerC, et al. (1999) Four cases with chronic intestinal pseudo-obstruction due to hollow visceral myopathy. Hepatogastroenterology 46: 349–352.

7. HigmanD, PetersP, StewartM (1992) Familial hollow visceral myopathy with varying urological manifestations. Br J Urol 70: 435–438.

8. ToyosakaA, OkamotoE, OkasoraT, NoseK, TomimotoY (1993) Clinical, laboratory and prognostic features of congenital large intestinal motor dysfunction (pseudo-Hirschsprung's disease). Clin Auton Res 3: 243–248.

9. PuriP, GosemannJH (2012) Variants of Hirschsprung disease. Semin Pediatr Surg 21: 310–318.

10. ChamyanG, Debich-SpicerD, OpitzJM, Gilbert-BarnessE (2001) Megacystis-microcolon-intestinal hypoperistalsis syndrome and aganglionosis in trisomy 18. Am J Med Genet 102: 293–296.

11. CouperRT, ByardRW, CutzE, StringerDA, DuriePR (1991) Cardiac rhabdomyomata and megacystis-microcolon-intestinal hypoperistalsis syndrome. J Med Genet 28: 274–276.

12. SzigetiR, ChumpitaziBP, FinegoldMJ, RanganathanS, CraigenWJ, et al. (2010) Absent smooth muscle actin immunoreactivity of the small bowel muscularis propria circular layer in association with chromosome 15q11 deletion in megacystis-microcolon-intestinal hypoperistalsis syndrome. Pediatr Dev Pathol 13: 322–325.

13. FarrellSA (1988) Intrauterine death in megacystis-microcolon-intestinal hypoperistalsis syndrome. J Med Genet 25: 350–351.

14. AnnerenG, MeurlingS, OlsenL (1991) Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS), an autosomal recessive disorder: clinical reports and review of the literature. Am J Med Genet 41: 251–254.

15. NarayananM, MurphyMS, AinsworthJR, ArulGS (2007) Mydriasis in association with MMIHS in a female infant: evidence for involvement of the neuronal nicotinic acetylcholine receptor. J Pediatr Surg 42: 1288–1290.

16. GarberA, ShohatM, SartiD (1990) Megacystis-microcolon-intestinal hypoperistalsis syndrome in two male siblings. Prenat Diagn 10: 377–387.

17. WinterRM, KnowlesSA (1986) Megacystis-microcolon-intestinal hypoperistalsis syndrome: confirmation of autosomal recessive inheritance. J Med Genet 23: 360–362.

18. McNamaraHM, OnwudeJL, ThorntonJG (1994) Megacystis-microcolon-intestinal hypoperistalsis syndrome: a case report supporting autosomal recessive inheritance. Prenat Diagn 14: 153–154.

19. KirtaneJ, TalwalkerV, DasturDK (1984) Megacystis, microcolon, intestinal hypoperistalsis syndrome: possible pathogenesis. J Pediatr Surg 19: 206–208.

20. LehtonenHJ, SipponenT, TojkanderS, KarikoskiR, JarvinenH, et al. (2012) Segregation of a missense variant in enteric smooth muscle actin gamma-2 with autosomal dominant familial visceral myopathy. Gastroenterology 143: 1482–1491 e1483.

21. PuriP, LakeBD, GormanF, O'DonnellB, NixonHH (1983) Megacystis-microcolon-intestinal hypoperistalsis syndrome: a visceral myopathy. J Pediatr Surg 18: 64–69.

22. RolleU, O'BriainS, PearlRH, PuriP (2002) Megacystis-microcolon-intestinal hypoperistalsis syndrome: evidence of intestinal myopathy. Pediatr Surg Int 18: 2–5.

23. PiotrowskaAP, RolleU, ChertinB, De CaluweD, BianchiA, et al. (2003) Alterations in smooth muscle contractile and cytoskeleton proteins and interstitial cells of Cajal in megacystis microcolon intestinal hypoperistalsis syndrome. J Pediatr Surg 38: 749–755.

24. TaguchiT, IkedaK, ShonoT, GotoS, KubotaM, et al. (1989) Autonomic innervation of the intestine from a baby with megacystis microcolon intestinal hypoperistalsis syndrome: I. Immunohistochemical study. J Pediatr Surg 24: 1264–1266.

25. Piaseczna PiotrowskaA, RolleU, SolariV, PuriP (2004) Interstitial cells of Cajal in the human normal urinary bladder and in the bladder of patients with megacystis-microcolon intestinal hypoperistalsis syndrome. BJU Int 94: 143–146.

26. RolleU, Piaseczna-PiotrowskaA, PuriP (2007) Interstitial cells of Cajal in the normal gut and in intestinal motility disorders of childhood. Pediatr Surg Int 23: 1139–1152.

27. XuW, GelberS, Orr-UrtregerA, ArmstrongD, LewisRA, et al. (1999) Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A 96: 5746–5751.

28. XuW, Orr-UrtregerA, NigroF, GelberS, SutcliffeCB, et al. (1999) Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci 19: 9298–9305.

29. RichardsonCE, MorganJM, JasaniB, GreenJT, RhodesJ, et al. (2001) Megacystis-microcolon-intestinal hypoperistalsis syndrome and the absence of the alpha3 nicotinic acetylcholine receptor subunit. Gastroenterology 121: 350–357.

30. MoserN, MechawarN, JonesI, Gochberg-SarverA, Orr-UrtregerA, et al. (2007) Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J Neurochem 102: 479–492.

31. Lev-LehmanE, BercovichD, XuW, StocktonDW, BeaudetAL (2001) Characterization of the human beta4 nAChR gene and polymorphisms in CHRNA3 and CHRNB4. J Hum Genet 46: 362–366.

32. RiviereJB, van BonBW, HoischenA, KholmanskikhSS, O'RoakBJ, et al. (2012) De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. Nat Genet 44: 440–444, S441–442.

33. Di DonatoN, RumpA, KoenigR, Der KaloustianVM, HalalF, et al. (2013) Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. Eur J Hum Genet 22 ((2)) 179–83.

34. MullerM, MazurAJ, BehrmannE, DiensthuberRP, RadkeMB, et al. (2012) Functional characterization of the human alpha-cardiac actin mutations Y166C and M305L involved in hypertrophic cardiomyopathy. Cell Mol Life Sci 69: 3457–3479.

35. LaingNG, WiltonSD, AkkariPA, DoroszS, BoundyK, et al. (1995) A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet 9: 75–79.

36. NakamuraY, GojoboriT, IkemuraT (2000) Codon usage tabulated from international DNA sequence databases: status for the year 2000. Nucleic Acids Res 28: 292.

37. PlotkinJB, KudlaG (2011) Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet 12: 32–42.

38. FayyazM, LacknerJM (2008) Serotonin receptor modulators in the treatment of irritable bowel syndrome. Ther Clin Risk Manag 4: 41–48.

39. HiradfarM, ShojaeianR, DehghanianP, HajianS (2013) Megacystis microcolon intestinal hypoperistalsis syndrome. BMJ Case Rep doi:10.1136/bcr-2012-007524

40. GiulianiS, VendryesC, MalhotraA, ShaulDB, AnselmoDM (2010) Prune belly syndrome associated with cloacal anomaly, patent urachal remnant, and omphalocele in a female infant. J Pediatr Surg 45: e39–42.

41. ManabeN, WongBS, CamilleriM (2010) New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs 19: 765–775.

42. CarrollJB, WarbySC, SouthwellAL, DotyCN, GreenleeS, et al. (2011) Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene/allele-specific silencing of mutant huntingtin. Mol Ther 19: 2178–2185.

43. AshrafianH, McKennaWJ, WatkinsH (2011) Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. Circ Res 109: 86–96.

44. SparrowJC, NowakKJ, DurlingHJ, BeggsAH, Wallgren-PetterssonC, et al. (2003) Muscle disease caused by mutations in the skeletal muscle alpha-actin gene (ACTA1). Neuromuscul Disord 13: 519–531.

45. WeberA, Franzini-ArmstrongC (2002) Hugh E. Huxley: birth of the filament sliding model of muscle contraction. Trends Cell Biol 12: 243–245.

46. SeidmanCE, SeidmanJG (2011) Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res 108: 743–750.

47. RahimovF, KunkelLM (2013) The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy. J Cell Biol 201: 499–510.

48. GuoDC, PannuH, Tran-FaduluV, PapkeCL, YuRK, et al. (2007) Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 39: 1488–1493.

49. ZhuL, VranckxR, Khau Van KienP, LalandeA, BoissetN, et al. (2006) Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 38: 343–349.

50. MilewiczDM, OstergaardJR, Ala-KokkoLM, KhanN, GrangeDK, et al. (2010) De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A 152A: 2437–2443.

51. RicherJ, MilewiczDM, GowR, de NanassyJ, MaharajhG, et al. (2012) R179H mutation in ACTA2 expanding the phenotype to include prune-belly sequence and skin manifestations. Am J Med Genet A 158A: 664–668.

52. ThorsonW, Diaz-HortaO, FosterJ2nd, SpiliopoulosM, QuinteroR, et al. (2013) De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis. Hum Genet

53. LupskiJR, Gonzaga-JaureguiC, YangY, BainbridgeMN, JhangianiS, et al. (2013) Exome sequencing resolves apparent incidental findings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy. Genome Med 5: 57.

54. BainbridgeMN, WangM, WuY, NewshamI, MuznyDM, et al. (2011) Targeted enrichment beyond the consensus coding DNA sequence exome reveals exons with higher variant densities. Genome Biol 12: R68.

55. ChallisD, YuJ, EvaniUS, JacksonAR, PaithankarS, et al. (2012) An integrative variant analysis suite for whole exome next-generation sequencing data. BMC Bioinformatics 13: 8.

56. DanecekP, AutonA, AbecasisG, AlbersCA, BanksE, et al. (2011) The variant call format and VCFtools. Bioinformatics 27: 2156–2158.

57. BainbridgeMN, WiszniewskiW, MurdockDR, FriedmanJ, Gonzaga-JaureguiC, et al. (2011) Whole-genome sequencing for optimized patient management. Sci Transl Med 3: 87re83.

58. UntergasserA, CutcutacheI, KoressaarT, YeJ, FairclothBC, et al. (2012) Primer3–new capabilities and interfaces. Nucleic Acids Res 40: e115.

59. BurlandTG (2000) DNASTAR's Lasergene sequence analysis software. Methods Mol Biol 132: 71–91.

60. McWilliamH, LiW, UludagM, SquizzatoS, ParkYM, et al. (2013) Analysis Tool Web Services from the EMBL-EBI. Nucleic Acids Res 41 ((Web Server issue)) W597–600.